{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:09:10Z","timestamp":1740632950272,"version":"3.38.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,25]]},"DOI":"10.7759\/cureus.79664","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:44:32Z","timestamp":1740548672000},"source":"Crossref","is-referenced-by-count":0,"title":["Therapy-Related B-cell Acute Lymphoblastic Leukemia: A Case Series and Literature Review"],"prefix":"10.7759","author":[{"given":"Hiba","family":"Asif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammarah","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed W","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bushra","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update","volume":"7","author":"Terwilliger T","year":"2017","unstructured":"Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017, 7:e577. 10.1038\/bcj.2017.53","journal-title":"Blood Cancer J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06337.x","article-title":"Down syndrome and acute lymphoblastic leukaemia","volume":"135","author":"Whitlock JA","year":"2006","unstructured":"Whitlock JA. Down syndrome and acute lymphoblastic leukaemia. Br J Haematol. 2006, 135:595-602. 10.1111\/j.1365-2141.2006.06337.x","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830450117","article-title":"Acute lymphoblastic leukemia in Fanconi's anemia","volume":"45","author":"Yetgin S","year":"1994","unstructured":"Yetgin S, Tuncer M, G\u00fcler E, Duru F, Ali Kasifolu M. Acute lymphoblastic leukemia in Fanconi's anemia. Am J Hematol. 1994, 45:94. 10.1002\/ajh.2830450117","journal-title":"Am J Hematol"},{"key":"ref4","article-title":"Bloom's syndrome: the German experience","volume":"34","author":"Passarge E","year":"1991","unstructured":"Passarge E. Bloom's syndrome: the German experience. Ann Genet. 1991, 34:179-97.","journal-title":"Ann Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba H","year":"2013","unstructured":"Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013, 381:1943-55. 10.1016\/S0140-6736(12)62187-4","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016, 127:2391-405. 10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-301713","article-title":"The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML","volume":"117","author":"Kayser S","year":"2011","unstructured":"Kayser S, D\u00f6hner K, Krauter J, et al.. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood. 2011, 117:2137-45. 10.1182\/blood-2010-08-301713","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000925","article-title":"Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes","volume":"3","author":"Saygin C","year":"2019","unstructured":"Saygin C, Kishtagari A, Cassaday RD, et al.. Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes. Blood Adv. 2019, 3:4228-37. 10.1182\/bloodadvances.2019000925","journal-title":"Blood Adv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.200311","article-title":"Therapy-related acute lymphoblastic leukemia","volume":"103","author":"Ribera JM","year":"2018","unstructured":"Ribera JM. Therapy-related acute lymphoblastic leukemia. Haematologica. 2018, 103:1581-3. 10.3324\/haematol.2018.200311","journal-title":"Haematologica"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2022.100297","article-title":"A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia","volume":"17","author":"Shikdar S","year":"2022","unstructured":"Shikdar S, Ying Y, Khawandanah M. A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia. Leuk Res Rep. 2022, 17:100297. 10.1016\/j.lrr.2022.100297","journal-title":"Leuk Res Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.06.001","article-title":"Therapy-related acute lymphoblastic leukemia: where do we stand with regards to its definition and characterization?","volume":"37","author":"Aldoss I","year":"2019","unstructured":"Aldoss I, Douer D, Pullarkat V. Therapy-related acute lymphoblastic leukemia: where do we stand with regards to its definition and characterization?. Blood Rev. 2019, 37:100584. 10.1016\/j.blre.2019.06.001","journal-title":"Blood Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.193599","article-title":"Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients","volume":"103","author":"Aldoss I","year":"2018","unstructured":"Aldoss I, Stiller T, Tsai NC, et al.. Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients. Haematologica. 2018, 103:1662-8. 10.3324\/haematol.2018.193599","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17008","article-title":"Shared clonal IGH rearrangement in BCP-ALL occurring after CLL: pitfalls and implications for MRD monitoring","volume":"191","author":"Derrieux C","year":"2020","unstructured":"Derrieux C, Gish A, Caulier A, et al.. Shared clonal IGH rearrangement in BCP-ALL occurring after CLL: pitfalls and implications for MRD monitoring. Br J Haematol. 2020, 191:506-9. 10.1111\/bjh.17008","journal-title":"Br J Haematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1977.03630200061017","article-title":"Chronic lymphocytic leukemia terminating in acute leukemia","volume":"137","author":"Zarrabi MH","year":"1977","unstructured":"Zarrabi MH, Gr\u00fcnwald HW, Rosner F. Chronic lymphocytic leukemia terminating in acute leukemia. Arch Intern Med. 1977, 137:1059-54. 10.1001\/archinte.1977.03630200061017","journal-title":"Arch Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPXE5VMONMVLZ0","article-title":"B-lymphoblastic leukemia in patients with chronic lymphocytic leukemia: a report of four cases","volume":"144","author":"Chakhachiro Z","year":"2015","unstructured":"Chakhachiro Z, Yin CC, Abruzzo LV, et al.. B-lymphoblastic leukemia in patients with chronic lymphocytic leukemia: a report of four cases. Am J Clin Pathol. 2015, 144:333-40. 10.1309\/AJCPXE5VMONMVLZ0","journal-title":"Am J Clin Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-819276","article-title":"Transformation of chronic lymphocytic leukemia into B-cell acute lymphoblastic leukemia","volume":"131","author":"Yun S","year":"2018","unstructured":"Yun S, Zhang L, Patel MR, Knepper TC, Chavez JC, Pinilla-Ibarz J. Transformation of chronic lymphocytic leukemia into B-cell acute lymphoblastic leukemia. Blood. 2018, 131:1258-61. 10.1182\/blood-2017-11-819276","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/187848-therapy-related-b-cell-acute-lymphoblastic-leukemia-a-case-series-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:44:33Z","timestamp":1740548673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/187848-therapy-related-b-cell-acute-lymphoblastic-leukemia-a-case-series-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.79664","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,25]]}}}